The Mechanisms of Diameter Changes in Retinal Vessels During Hypoxia
NCT02059018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2015-08-19
Summary
The primary objective is to study if a stimulation of nitric oxide and/or prostaglandin affect the diameter changes of retinal vessels during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.
Conditions
- Retinal Hypoxia
Interventions
- DRUG
-
COX-inhibitor
Administration of 1 drop voltaren 45 minutes before recordings of diameter changes of retinal vessels are initiated
- DRUG
-
Nitroglycerin
Oral administration of tablet nitroglycerin 0,5mg 5 minutes before recordings of diameter changes of retinal vessels are initiated
- DRUG
-
COX-inhibitor + Nitroglycerin
Combination of COX-inhibitor and nitroglycerin interventions.
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Line Pedersen, MD · Aarhus University Hospital
-
Musa Kaya, stud.med · Aarhus University Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2015-02-28
- Completion
- 2015-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and Normoxia
NCT01905696 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity
NCT04612270 ·Status: COMPLETED ·Phase: NA
-
The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery
NCT00814047 ·Status: COMPLETED ·Phase: PHASE4
-
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
NCT03738943 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Influence of Nitric Oxide on Flow Mediated Dilation
NCT03723278 ·Status: COMPLETED
-
Testosterone and Neurovascular Control in Humans
NCT04819204 ·Status: UNKNOWN ·Phase: NA
-
Tracing Changed Production of Red Blood Cells
NCT05833477 ·Status: COMPLETED ·Phase: NA
-
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
NCT01137656 ·Status: COMPLETED ·Phase: PHASE1
-
Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers
NCT01774994 ·Status: COMPLETED ·Phase: NA
-
Caffeine and Cerebrovascular Reactivity
NCT04730193 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of C21 on Forearm Blood Flow
NCT05277922 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Berkeley Life Oral Nitrate Supplementation
NCT06777108 ·Status: COMPLETED ·Phase: NA
-
Role of Adenosine in the Release of VEGF and Cytokines
NCT00580905 ·Status: TERMINATED ·Phase: PHASE1
-
Salmeterol Effect on Exercise Performance
NCT06655012 ·Status: RECRUITING ·Phase: NA
-
Determination of Drugs and Their Metabolites in Hospitalized Patients
NCT01702545 ·Status: UNKNOWN
-
Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity
NCT00175968 ·Status: COMPLETED ·Phase: PHASE1
-
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
NCT00430170 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
NCT03680404 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Nasal Breathing for Perfomance in Elite Athletes.
NCT06480071 ·Status: COMPLETED ·Phase: NA
-
Vascular Endothelial Protection Effects of Dextromethorphan
NCT00605605 ·Status: COMPLETED ·Phase: PHASE4
-
L-Citrulline and Endothelial Function
NCT05722860 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE)
NCT04920695 ·Status: COMPLETED ·Phase: NA
-
Lung Diffusing Capacity for Nitric Oxide During Cycling Exercise
NCT04618302 ·Status: COMPLETED
-
Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness
NCT00745771 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During Exercise
NCT02965963 ·Status: COMPLETED ·Phase: NA